Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC UNC10217938A | 1347749-97-6 | 99.75% | 456.54 | 50 MG
SDP

Catalog No. 5000348394
Encompass_Preferred

UNC10217938A is a 3-deazapteridine analog with strong oligonucleotide enhancing effects. It enhances oligonucleotides effects by modulating their intracellular trafficking and release from endosomes, and also enhances the effects of antisense and siRNA oligonucleotides.

  • 3-deazapteridine analog with strong oligonucleotide enhancing effects.
  • Enhances oligonucleotide effects by modulating intracellular trafficking and release from endosomes.
  • Enhances the effects of antisense and siRNA oligonucleotides.
  • Strongly enhances luciferase induction in HelaLuc705 cells.
  • Can substantially enhance effects of receptor targeted oligonucleotide conjugates.
  • Can enhance effects of uncharged morpholino oligonucleotides as well as negatively charged oligonucleotides.
  • Causes partial release of oligonucleotide from late endosomes to the cytosol followed by nuclear accumulation.

Catalog No. 50-003-48394 Supplier Medchemexpress LLC Supplier No. HY13615150MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

UNC10217938A is a 3-deazapteridine analog with strong oligonucleotide enhancing effects. It enhances oligonucleotides effects by modulating their intracellular trafficking and release from endosomes, and also enhances the effects of antisense and siRNA oligonucleotides.

  • 3-deazapteridine analog with strong oligonucleotide enhancing effects.
  • Enhances oligonucleotide effects by modulating intracellular trafficking and release from endosomes.
  • Enhances the effects of antisense and siRNA oligonucleotides.
  • Strongly enhances luciferase induction in HelaLuc705 cells.
  • Can substantially enhance effects of receptor targeted oligonucleotide conjugates.
  • Can enhance effects of uncharged morpholino oligonucleotides as well as negatively charged oligonucleotides.
  • Causes partial release of oligonucleotide from late endosomes to the cytosol followed by nuclear accumulation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.